EPIVIR - 0179-0087-70 - (lamivudine)

Alphabetical Index


Drug Information of EPIVIR

Product NDC: 0179-0087
Proprietary Name: EPIVIR
Non Proprietary Name: lamivudine
Active Ingredient(s): 150    mg/1 & nbsp;   lamivudine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of EPIVIR

Product NDC: 0179-0087
Labeler Name: KAISER FOUNDATION HOSPITALS
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020564
Marketing Category: NDA
Start Marketing Date: 20110315

Package Information of EPIVIR

Package NDC: 0179-0087-70
Package Description: 30 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (0179-0087-70)

NDC Information of EPIVIR

NDC Code 0179-0087-70
Proprietary Name EPIVIR
Package Description 30 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (0179-0087-70)
Product NDC 0179-0087
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name lamivudine
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110315
Marketing Category Name NDA
Labeler Name KAISER FOUNDATION HOSPITALS
Substance Name LAMIVUDINE
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of EPIVIR


General Information